Tower Capital, Temasek Joins $196M Take-Private Bid For Eu Yan Sang

Tower Capital and Temasek Holdings have joined company founders to submit a bid to take Singapore-listed traditional Chinese medicine firm Eu Yan Sang International private in a deal that values the company at S$269 million (US$196 million).

China Money Network

Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Register Now

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!

Already have an account or paid subscription? Log in

Caishen.Co - Primary Data for China Secondary Investment and Stock Markets